VC firm
VenBio Partners
Also known as venBio Global Strategic, venBio Global Strategic Fund II L.P., venBio Global Strategic Fund III, L.P., venBio Global Strategic Fund IV, L.P., venBio Global Strategic Fund V, L.P., venBio Global Strategic Fund, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- SAN FRANCISCO, CA, United States
- Assets under management
- $1.1BStated by firm, as of 2026-09-18Source (opens in a new tab)
- Latest fund size
- $505MSEC amount sold, as of 2024-07-12Source (opens in a new tab)
- Funds
- 6
- Legal name
- venBio Partners LLC
Claim, correct or request removal
Record updated 27 September 2026
About
We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.
Investment approach
- Thesis
- We seek out teams who are developing treatments that will have a meaningful impact on patient care. Our mission is to put our companies in the best possible position to succeed, by helping teams think through the best development plan to bring these therapies to patients.Source (opens in a new tab)
- Investing status notes
- We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.
Funds
- venBio Global Strategic Fund V, L.P.
- $505MVintage 2024, Main fund, SEC amount sold
- venBio Global Strategic Fund IV, L.P.
- $550MVintage 2021, Main fund, SEC amount sold
- venBio Global Strategic Fund III, L.P.
- $386MVintage 2018, Main fund, SEC amount sold
- venBio Global Strategic Fund II L.P.
- $337MVintage 2015, Main fund, SEC amount sold
- venBio Global Strategic Fund, L.P.
- $177MVintage 2010, SPV, SEC amount sold
- VENBIO GLOBAL STRATEGIC FUND V, L.P.
- Main fund
SEC registration
- Registered adviser
- VENBIO PARTNERS LLC
- CRD number
- 290045 (opens in a new tab)
- SEC file number
- 802-111956
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $1.8Bas of 2026-03-12
- Private funds reported
- 5
- Principal office
- SAN FRANCISCO, CA, United States
- SEC CIK
- 1504130, 1634632, 1739920
Locations
- Office
- San Francisco, CA, United States
- Office
- Seattle, WA, United States
Loading relationship preview